🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆
Updated 06 Sep 2026 · ClinicalTrials.gov

Clinical Trials in Arizona

← All US trials

The most recently updated industry-sponsored clinical trials recruiting across the United States — searchable by condition, sponsor, phase and state. Refreshed daily from the ClinicalTrials.gov registry.

42
Recruiting now
66
Studies tracked
Arizona
Selected state
Recruiting Phase 3
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company · started 2023-08-28
Arizona · California · Florida · Georgia · Illinois · Louisiana · Michigan · Mississippi
NCT06126224 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
Advanced Solid Tumor, Adult, ERBB2 Altered Breast Cancer, ERBB2 Gene Amplification, HER2 Overexpression
Cogent Biosciences, Inc. · started 2025-12-30
Arizona · Connecticut · Florida · Illinois · Louisiana · Michigan · Minnesota · Missouri
NCT07361562 on ClinicalTrials.gov ↗
Active Phase 3
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals · started 2023-03-09
Alabama · Arizona · California · Colorado · Connecticut · Florida · Georgia · Hawaii
NCT05739383 on ClinicalTrials.gov ↗
Recruiting Phase 4
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Pfizer · started 2025-05-07
Arizona · California · Colorado · Florida · Georgia · Illinois · Indiana · Kentucky
NCT06952660 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
Atopic Dermatitis, Eczema, Atopic
Pfizer · started 2025-11-20
Arizona · California · Florida · New York · Pennsylvania
NCT07216027 on ClinicalTrials.gov ↗
Active Phase 2
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
Solid Tumors
Hoffmann-La Roche · started 2021-01-18
Arizona · California · Georgia · Idaho · Illinois · Indiana · Maryland · Michigan
NCT04589845 on ClinicalTrials.gov ↗
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
Stryker Instruments · started 2017-03-10
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware
NCT03072927 on ClinicalTrials.gov ↗
Recruiting Phase 2
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
Graves' Disease
Yarrow Bioscience, Inc. · started 2026-06-10
Arizona · California · Florida · Georgia · Kentucky · Michigan · Nebraska · New York
NCT07682896 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
Alcohol Use Disorder
Eli Lilly and Company · started 2025-10-15
Alabama · Arizona · Arkansas · California · Colorado · Florida · Illinois · Maryland
NCT07219966 on ClinicalTrials.gov ↗
Starting soon Phase 2
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
PARKINSON DISEASE (Disorder)
Vima Therapeutics · started 2026-09
Arizona · California · Connecticut · Florida · Georgia · Kansas · Maryland · Michigan
NCT07804615 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to Moderate Lumbar Degenerative Disc Disease
Degenerative Disc Disease
DiscGenics, Inc. · started 2025-12-23
Alabama · Arizona · California · District of Columbia · Florida · Idaho · Indiana · Kentucky
NCT07254806 on ClinicalTrials.gov ↗
Recruiting
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Heart Failure - NYHA II - IV
Boston Scientific Corporation · started 2025-10-22
Alabama · Arizona · Arkansas · California · District of Columbia · Florida · Georgia · Illinois
NCT07069738 on ClinicalTrials.gov ↗
Active Phase 3
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
Prostate Cancer
Pfizer · started 2021-05-12
Alabama · Arizona · California · Connecticut · District of Columbia · Florida · Georgia · Illinois
NCT04821622 on ClinicalTrials.gov ↗
Recruiting Phase 2
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
Plaque Psoriasis
Oruka Therapeutics, Inc. · started 2026-02-23
Arizona · California · Connecticut · Florida · Illinois · Kentucky · Maryland · Massachusetts
NCT07449702 on ClinicalTrials.gov ↗
Recruiting Phase 3
Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)
Hereditary Angioedema (HAE), Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2, HAE
ADARx Pharmaceuticals, Inc. · started 2026-04-02
Arizona · Arkansas · California · Florida · Maryland · Michigan · Missouri · Nevada
NCT07428499 on ClinicalTrials.gov ↗
Active Phase 2
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
Hypertension
Novartis Pharmaceuticals · started 2025-03-26
Alabama · Arizona · California · Florida · Georgia · Idaho · Illinois · Indiana
NCT06857955 on ClinicalTrials.gov ↗
Recruiting Phase 3
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
Immuneering Corporation · started 2026-06-05
Alabama · Arizona · California · Colorado · Delaware · Florida · Georgia · Illinois
NCT07562152 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
Graves' Disease
Biogen · started 2026-07-30
Arizona · California · Florida · North Carolina · Texas
NCT07722546 on ClinicalTrials.gov ↗
Recruiting
Patient Retrospective Outcomes (PRO)
Chronic Pain
Boston Scientific Corporation · started 2012-04-03
Arizona · California · Colorado · Connecticut · Florida · Georgia · Hawaii · Idaho
NCT01550575 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Brenipatide in Participants With Opioid Use Disorder
Opioid Use Disorder
Eli Lilly and Company · started 2026-02-13
Arizona · Arkansas · California · Florida · Illinois · Indiana · Kentucky · Maryland
NCT07420283 on ClinicalTrials.gov ↗
Active Phase 1/Phase 2
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm
AbbVie · started 2018-01-02
Alabama · Arizona · California · Florida · Maryland · Massachusetts · New York · North Carolina
NCT03386513 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
Relapsed or Refractory Large B-cell Lymphoma
Kite, A Gilead Company · started 2026-05-22
Arizona · California · Colorado · Connecticut · Florida · Georgia · Illinois · Missouri
NCT07479797 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Ovarian Neoplasms, Endometrial Neoplasms, Uterine Cervical Neoplasms, Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company · started 2024-05-20
Arizona · California · Georgia · Michigan · New York · Ohio · Texas · Utah
NCT06400472 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Melanoma (Skin Cancer), HER2-low Hormone Receptor Positive Breast Cancer
Aminex Therapeutics, Inc. · started 2026-01-26
Arizona · California · Colorado · Kansas · Michigan · Minnesota · New York · Ohio
NCT07287917 on ClinicalTrials.gov ↗
By invitation Phase 3
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
UCB Biopharma SRL · started 2021-07-27
Alabama · Arizona · California · Colorado · Florida · Georgia · Idaho · Illinois
NCT04976322 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults
Chronic Migraine
Ipsen · started 2023-10-12
Alabama · Arizona · California · Colorado · Connecticut · Florida · Georgia · Illinois
NCT06047444 on ClinicalTrials.gov ↗
Recruiting Phase 1
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
Solid Tumor
ImmunoGenesis · started 2023-09-07
Arizona · California · Florida · Kentucky · Louisiana · Missouri · Pennsylvania · Texas
NCT06014502 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
Advanced Prostate Cancer, Metastatic Prostate Cancer
Genentech, Inc. · started 2026-04-29
Arizona · Tennessee
NCT07567846 on ClinicalTrials.gov ↗
Active Phase 3
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Non-alcoholic Steatohepatitis
Novo Nordisk A/S · started 2021-04-01
Alabama · Arizona · Arkansas · California · Colorado · Connecticut · Florida · Georgia
NCT04822181 on ClinicalTrials.gov ↗
Recruiting Phase 3
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals · started 2026-05-11
Alabama · Arizona · Arkansas · California · Colorado · Connecticut · Florida · Georgia
NCT07517263 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
UCB Biopharma SRL · started 2024-11-21
Arizona · Arkansas · California · Colorado · Florida · Georgia · Illinois · Indiana
NCT06617325 on ClinicalTrials.gov ↗
Recruiting Phase 3
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Non-small Cell Lung Cancer (NSCLC)
AstraZeneca · started 2025-10-31
Arizona · California · Colorado · Delaware · District of Columbia · Florida · Georgia · Illinois
NCT07291037 on ClinicalTrials.gov ↗
Recruiting Phase 4
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
Eli Lilly and Company · started 2026-03-09
Alabama · Arizona · Florida · Minnesota · New York · Ohio · Texas
NCT07218341 on ClinicalTrials.gov ↗
Active Phase 2
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Diabetic Retinopathy
Boehringer Ingelheim · started 2024-05-15
Arizona · California · Colorado · Connecticut · Florida · Hawaii · Maine · Maryland
NCT06321302 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
HIV-1-infection
Gilead Sciences · started 2026-06-15
Arizona · California · Colorado · Florida · Georgia · Michigan · Missouri · New Jersey
NCT07645287 on ClinicalTrials.gov ↗
Active Phase 3
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Obesity and Overweight
Pfizer · started 2025-12-19
Arizona · California · Colorado · Florida · Georgia · Maryland · Missouri · Nebraska
NCT07311850 on ClinicalTrials.gov ↗
Active Phase 1
A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors
Renal Cell Carcinoma, Ovarian Tumor
Daiichi Sankyo · started 2020-12-22
Arizona · Colorado · Florida · Oklahoma · Tennessee
NCT04707248 on ClinicalTrials.gov ↗
Recruiting Phase 2/Phase 3
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Neoplasms
Celgene · started 2018-07-19
Alabama · Arizona · California · Colorado · Connecticut · District of Columbia · Florida · Georgia
NCT03435796 on ClinicalTrials.gov ↗
Recruiting Phase 3
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Axsome Therapeutics, Inc. · started 2026-01-14
Arizona · Arkansas · California · Connecticut · Florida · Georgia · Illinois · Kansas
NCT07398417 on ClinicalTrials.gov ↗
Recruiting Phase 3
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company · started 2025-09-02
Alabama · Arizona · California · Colorado · Connecticut · Florida · Georgia · Idaho
NCT07157774 on ClinicalTrials.gov ↗
Active Phase 2
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss
Obesity & Overweight, Mobility Disability, HOMA-IR
Veru Inc. · started 2026-03-26
Arizona · Florida · Louisiana · Maryland · Mississippi · New York · North Carolina · Texas
NCT07446998 on ClinicalTrials.gov ↗
Active
SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN
Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases
Medtronic Vascular · started 2021-10-20
Alabama · Arizona · Arkansas · California · Colorado · Connecticut · District of Columbia · Florida
NCT05198674 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced, Metastatic Solid Tumors, Lung Cancers
Avenzo Therapeutics, Inc. · started 2025-06-04
Arizona · California · Colorado · Connecticut · District of Columbia · Florida · Georgia · Massachusetts
NCT07038343 on ClinicalTrials.gov ↗
Recruiting Phase 4
Dabrafenib and/or Trametinib Rollover Study
Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers
Novartis Pharmaceuticals · started 2018-01-26
Arizona · Maryland · Ohio · Texas
NCT03340506 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Breast Neoplasms
Eli Lilly and Company · started 2026-05-13
Alabama · Arizona · California · Colorado · Florida · Georgia · Indiana · Kentucky
NCT07287098 on ClinicalTrials.gov ↗
Active Phase 1/Phase 2
First-in-Human Study of ICT01 in Patients With Advanced Cancer
Solid Tumor, Adult, Hematopoietic/Lymphoid Cancer
ImCheck Therapeutics, an Ipsen company · started 2020-03-05
Arizona · California · Connecticut · Florida · New York · Texas · Washington
NCT04243499 on ClinicalTrials.gov ↗
Active Phase 2/Phase 3
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus
Biogen · started 2022-09-13
Alabama · Arizona · California · Colorado · Florida · Georgia · Illinois · Indiana
NCT05531565 on ClinicalTrials.gov ↗
Recruiting Phase 3
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Early Breast Cancer
Novartis Pharmaceuticals · started 2024-02-28
Alabama · Alaska · Arizona · Arkansas · California · Colorado · District of Columbia · Florida
NCT05827081 on ClinicalTrials.gov ↗
Recruiting Phase 3
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Ferring Pharmaceuticals · started 2024-10-01
Alabama · Arizona · Arkansas · California · Colorado · District of Columbia · Florida · Georgia
NCT06510374 on ClinicalTrials.gov ↗
Recruiting Phase 4
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Psoriasis, Overweight or Obesity
Eli Lilly and Company · started 2025-03-19
Arizona · California · Florida · Georgia · Indiana · Kentucky · Maryland · Massachusetts
NCT06857942 on ClinicalTrials.gov ↗
By invitation Phase 3
An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus
Systemic Lupus Erythematosus (SLE)
Biogen · started 2022-06-10
Arizona · California · Colorado · District of Columbia · Florida · Georgia · Massachusetts · Michigan
NCT05352919 on ClinicalTrials.gov ↗
Active Phase 2
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease
Parkinsons Disease
Hoffmann-La Roche · started 2021-05-05
Alabama · Arizona · California · Colorado · Connecticut · Florida · Illinois · Kansas
NCT04777331 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Neovascular Age-related Macular Degeneration
AbbVie · started 2025-11-05
Arizona · California · Colorado · Florida · Georgia · Illinois · Indiana · Iowa
NCT07007065 on ClinicalTrials.gov ↗
Active Phase 3
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
Overweight, Obesity, Type 2 Diabetes
Novo Nordisk A/S · started 2025-11-05
Alabama · Arizona · California · Florida · Hawaii · Indiana · Nevada · New York
NCT07220759 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
Chronic Pain, Low Back Pain
Eli Lilly and Company · started 2026-08-12
Alabama · Arizona · California · Connecticut · Florida · Georgia · Illinois · Louisiana
NCT07641504 on ClinicalTrials.gov ↗
Active
Aventus Thrombectomy System Pulmonary Embolism Clinical Study
Pulmonary Embolism, Embolism, Embolism and Thrombosis, Vascular Diseases
Inquis Medical, Inc. · started 2023-09-20
Arizona · California · Connecticut · District of Columbia · Georgia · Illinois · Indiana · Louisiana
NCT05907564 on ClinicalTrials.gov ↗
Recruiting
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
Parkinson's Disease
Bayer · started 2026-07-21
Arizona · California · Connecticut · Florida · Georgia · Illinois · Maryland · Massachusetts
NCT07330258 on ClinicalTrials.gov ↗
Starting soon Phase 2
A Study to Evaluate BMS-986511 in Adults With Major Depressive Disorder
Major Depressive Disorder
Bristol-Myers Squibb · started 2026-10-30
Arizona · Arkansas · California · Florida · Georgia · Maryland · Massachusetts · New York
NCT07772531 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults
Episodic Migraine
Ipsen · started 2023-09-29
Alabama · Arizona · California · Connecticut · Florida · Illinois · Indiana · Maryland
NCT06047457 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Osteoarthritis, Knee, Chronic Pain
Eli Lilly and Company · started 2026-06-25
Alabama · Arizona · California · Connecticut · Florida · Georgia · Illinois · Louisiana
NCT07641517 on ClinicalTrials.gov ↗
Active Phase 3
177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer
Metastasis From Malignant Tumor of Prostate
Curium US LLC · started 2022-02-14
Arizona · California · Florida · Illinois · Maryland · Michigan · Minnesota · Missouri
NCT05204927 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Non Small Cell Lung Carcinoma
AbbVie · started 2025-03-06
Arizona · California · Colorado · Florida · Illinois · Indiana · Kansas · Massachusetts
NCT06772623 on ClinicalTrials.gov ↗
Active Phase 3
A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
Moderate to Severe Glabellar Lines
Ipsen · started 2026-02-27
Alabama · Arizona · California · Florida · Maryland · South Carolina · Texas · Virginia
NCT07427797 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO)
EyeBiotech Ltd. · started 2025-09-12
Arizona · California · Colorado · Florida · Illinois · Maryland · Mississippi · New Jersey
NCT07205887 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Multiple Sclerosis (MS) Primary Progressive
Zenas BioPharma (USA), LLC · started 2026-03-23
Arizona · California · Florida · Kansas · Missouri · New Jersey · North Carolina · Ohio
NCT07067463 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Ulcerative Colitis
AbbVie · started 2025-07-28
Arizona · California · Florida · Georgia · Illinois · New Jersey · Ohio · Pennsylvania
NCT07071519 on ClinicalTrials.gov ↗
No trials match your search.

Browse by state

Florida · 121 California · 119 Arizona · 66 Georgia · 66 Illinois · 52 Colorado · 46 Connecticut · 39 New York · 36 Alabama · 36 Texas · 35 Maryland · 34 Indiana · 29 Massachusetts · 29 Michigan · 28 Missouri · 25 Arkansas · 24

Browse by condition

Obesity · 7 Overweight · 6 Atopic Dermatitis · 3 Hepatic Impairment · 3 Solid Tumors · 3 Breast Cancer · 3 Non-Small Cell Lung Cancer · 3 Solid Tumor · 3 Healthy · 3 Chronic Pain · 3 Diabetes Mellitus, Type 1 · 3 Breast Neoplasms · 3 Lumbar Spinal Stenosis · 2 Graves' Disease · 2 Solid Tumor, Adult · 2 Melanoma · 2
Cite this page

Priya Life Science (2026). Clinical Trials in the USA Tracker. Available at: https://priyalifescience.com/clinical-trials-usa/state/arizona (Accessed: 6 September 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one US site, most recently updated first, refreshed daily. This is a curated slice of the full registry, not every US trial. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish and EU sites, see our Ireland and EU trackers.